CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 277 filers reported holding CLOVIS ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $11,000 | +37.5% | 450 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $8,000 | -38.5% | 450 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $13,000 | -35.0% | 450 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $20,000 | -16.7% | 450 | 0.0% | 0.00% | -20.0% |
| Q1 2018 | $24,000 | +242.9% | 450 | +350.0% | 0.01% | +400.0% |
| Q4 2017 | $7,000 | -63.2% | 100 | -66.7% | 0.00% | -66.7% |
| Q1 2017 | $19,000 | +375.0% | 300 | +200.0% | 0.00% | +200.0% |
| Q3 2016 | $4,000 | -97.7% | 100 | -95.0% | 0.00% | -98.4% |
| Q2 2015 | $176,000 | – | 2,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |